This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Earnings Preview: Community Health Systems (CYH) Q2 Earnings Expected to Decline
by Zacks Equity Research
Community Health Systems (CYH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Universal Health Services (UHS) Q2 Earnings Expected to Decline
by Zacks Equity Research
Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXH
Universal Health (UHS) Cuts Guidance, Falls 6.1%: What's Ahead?
by Zacks Equity Research
Universal Health's (UHS) acute care hospitals experience lower-than-expected patient volumes in the second quarter, inducing a decline in revenues and profits.
Acadia Healthcare (ACHC) JV to Build Behavioral Health Hospital
by Zacks Equity Research
Acadia Healthcare (ACHC) enters into a JV with Massachusetts-based Tufts Medicine to construct a behavioral health hospital and address the dire need for better behavioral healthcare services across Boston.
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
by Zacks Equity Research
Sector ETF report for FXH
Why Is Universal Health Services (UHS) Down 3.1% Since Last Earnings Report?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXH
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
by Zacks Equity Research
Sector ETF report for FXH
Universal Health (UHS) Q1 Earnings Miss Mark, Tumble Y/Y
by Zacks Equity Research
Universal Health's (UHS) Q1 results reflect a steep expense level and lower admissions in its Behavioral Health Care Services segment, partially offset by revenue recognition.
Universal Health Services (UHS) Q1 Earnings Miss Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of -12.96% and 2.25%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Tenet Healthcare (THC) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 85.58% and 1.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Universal Health (UHS) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Universal Health Services' (UHS) first-quarter results are likely to reflect the benefits of increased admissions.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why You Should Retain Universal Health (UHS) Stock Now
by Zacks Equity Research
Increased admissions at both of its operating segments, constant initiatives to bolster its care network and adequate cash generation abilities are likely to drive Universal Health (UHS).
Acadia Healthcare (ACHC) JV Adds Service Line, Ups Bed Capacity
by Zacks Equity Research
Acadia Healthcare (ACHC) operated (through a JV) Southcoast Behavioral Health includes a pediatric service line and increases bed capacity to 192.
Acadia Healthcare (ACHC) Eyes Over 600 Bed Additions in 2022
by Zacks Equity Research
Acadia Healthcare (ACHC) has two de novo projects in Chicago and Indio, CA, which are expected to add a total of around 140 beds this year.
4 Stocks to Watch From the Flourishing Hospital Industry
by Kaibalya Pravo Dey
Rising patient volumes and the growing aging population are driving Zacks Medical-Hospital industry players' profits. HCA Healthcare, Universal Health, Tenet Healthcare and Mednax are poised to benefit from improving operating efficiency.
Universal Health (UHS) Q4 Earnings Beat on Higher Patient Days
by Zacks Equity Research
Universal Health Services (UHS) expects capital expenditures for 2022 to increase from the 2021 level to the range of $950-$1,100 million.
Universal Health Services (UHS) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of 4.24% and 4.15%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Universal Health (UHS) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Universal Health Services' (UHS) fourth-quarter results are likely to reflect the benefits of improving patient volumes.
Analysts Estimate Universal Health Services (UHS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mednax (MD) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Mednax (MD) delivered earnings and revenue surprises of 18.18% and 3.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Centene (CNC) Gears Up for Q4 Earnings: What Lies Ahead?
by Zacks Equity Research
Centene's (CNC) fourth-quarter results are likely to reflect growth in total membership.
Retail Loss to Affect Humana's (HUM) Q4 Earnings: Here's How
by Zacks Equity Research
Humana's (HUM) fourth-quarter results are likely to reflect growth in medical membership.